Patents by Inventor W Daniel Stamer

W Daniel Stamer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • S1P ANTAGONISTS AS ADJUNCT OCULAR HYPOTENSIVES
    Publication number: 20130079290
    Abstract: The invention provides compositions and methods for further reducing IOP in a subject who has already achieved maximal IOP reduction using known IOP lowering agents. The activity of an ocular hypotensive treatment regimen may be increased by adding an S1P antagonist to prevent S1P mediated reversal as a result of decreased aqueous humor outflow.
    Type: Application
    Filed: March 26, 2012
    Publication date: March 28, 2013
    Applicant: ALLERGAN, INC.
    Inventors: David F. Woodward, Todd M. Heidelbaugh, W. Daniel Stamer
  • Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells
    Patent number: 7803558
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: September 28, 2010
    Assignee: The Arizona Board of Regents on behalf of the University of Arizona
    Inventors: W Daniel Stamer, Ronald L Heimark
  • MODULATION OF AQUEOUS HUMOR OUTFLOW BY TARGETING VASCULAR-ENDOTHELIAL-CADHERIN IN SCHLEMM'S CANAL CELLS
    Publication number: 20090029404
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Application
    Filed: June 18, 2008
    Publication date: January 29, 2009
    Applicant: THE ARIZONA BD OF REG ON BEHALF OF THE UNIV OF AZ
    Inventors: W Daniel STAMER, Ronald L. Heimark
  • Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells
    Publication number: 20040167076
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 26, 2004
    Inventors: W. Daniel Stamer, Ronald L. Heimark